RxDoctor Payments DataLook up a doctor →

Tatyana Miroshnikova

Internal Medicine · Orlando, FLNPI 1104990761

Payments from drug & device makers

$4,153,027in general payments, 2019–2025

Across 1,142 payments — averaging $3636.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$1.4M
  • Amgen$785K
  • Eli Lilly$781K
  • Pfizer$606K
  • Alnylam Pharmaceuticals Inc.$152K
  • Novo Nordisk AS$133K
  • plus $315K from 10 others
$6,607in research payments, 2019–2025

Across 15 payments — averaging $440.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$3K
  • Sanofi US Services Inc.$2K
  • Lexicon Pharmaceuticals, Inc.$1K

What the payments were for

  • Travel & lodging$4,90172%
  • Food & beverage$1,95228%

General payments by program year

19
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,153,027 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Other internal medicine in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →